View Single Post
Old 03-04-2010, 01:05 PM   #2
1rarebird
Senior Member
 
Join Date: Feb 2010
Location: TN
Posts: 175
Re: New way tx her2...

Dr. Moasser at UCSF seems to be on to something with this research that would truely be game-changing, if these high doses of HER2 blockading agents (Tykerb and the like) can be tolerated by the patient. That's a big "if", but what he is doing seems to make a lot of sense.
bird
__________________
Male Breast Cancer, DX 5/15/09, IDC, STAGE 1, 1.7 cm, HER2+++, ER+(95%)/PR+(75%), Ki67 40%, grade 3, 0/5 nodes, TX: mastectomy, TCH finished 7/19/10, radiation 6 wks., Tamoxifen on going, bisphosphonate 24 mos.
1rarebird is offline   Reply With Quote